ISO 20166-4:2021

Overview

ISO 20166-4:2021 outlines standardized requirements and recommendations for the pre-examination processes of formalin-fixed and paraffin-embedded (FFPE) tissue specimens intended for in situ detection techniques. This standard supports quality and reliability in molecular in vitro diagnostic examinations by specifying ways to collect, handle, document, transport, store, and process FFPE tissue samples before in situ analysis. It applies to laboratories conducting qualitative and semi-quantitative examinations of tissue morphology and biomolecules (metabolites, proteins, DNA, and RNA) utilizing various in situ detection methods.

The document is relevant for histopathology and molecular pathology laboratories, clinical and biomedical research labs, in vitro diagnostics manufacturers, regulatory authorities, and biobanks, ensuring consistent results and dependable data for medical diagnostics, research, and personalized medicine.

Key Topics

• Pre-examination Workflow: Detailed steps for specimen collection, labeling, handling, transport, tissue processing, and documentation to preserve sample integrity prior to analysis.
• Specimen Handling: Guidelines to optimize tissue morphology and biomolecule stability, considering factors such as ischemia times and temperature control, thus reducing risks of degradation and analytical errors.
• Formalin Fixation and Paraffin Embedding: Specifications for fixation protocols, including the use of standard buffered formalin, fixation times, and embedding techniques to maintain sample quality.
• Sectioning and Slide Preparation: Requirements for section thickness, mounting, deparaffinization, rehydration, and pretreatment to facilitate reliable in situ detection.
• Quality and Safety: Procedures for preventing contamination, ensuring traceability, validating pre-examination processes, and meeting laboratory safety standards.
• In situ Detection Techniques Covered:
  • Classical histological staining (e.g. H&E)
  • Histochemical methods
  • Immunohistochemistry (IHC) and immunofluorescence
  • In situ hybridization (ISH), including FISH and CISH
  • Modern molecular localization techniques (e.g. in situ sequencing)

Applications

ISO 20166-4:2021 enhances the reliability of in vitro diagnostic tests that utilize FFPE tissue for in situ detection, crucial for accurate disease diagnosis and research. Key applications include:

• Pathology Laboratories: Enables reproducible histopathological and molecular analyses, supporting diagnostic decision-making and companion diagnostics in oncology.
• Molecular Pathology: Ensures biomolecule integrity for precise in situ hybridization and immunohistochemistry assessments.
• Biomedical Research: Facilitates reliable localization and quantification of biomolecules in tissue sections for academic and commercial research.
• In Vitro Diagnostics Development: Supports test developers and manufacturers in refining pre-examination protocols to maximize test validity and compliance.
• Biobanks and Regulatory Compliance: Provides a benchmark for sample processing and documentation, aiding biobank operations, regulatory reviews, and audits.

By standardizing pre-analytical processes, the standard minimises variation, underpins quality assurance, and supports the advancement of personalized medicine and digital pathology infrastructure.

Related Standards

ISO 20166-4:2021 forms part of a series of standards designed to address pre-analytical variables in molecular diagnostics:

• ISO 20166-1: General requirements for pre-examination processes for isolated RNA from FFPE tissue
• ISO 20166-2: Pre-examination specifications for isolated proteins from FFPE tissue
• ISO 20166-3: Specifications for isolated DNA from FFPE tissue
• ISO 15189: Medical laboratories - Requirements for quality and competence
• ISO 15190: Medical laboratories - Safety requirements

Additional standards address pre-examination for Fine Needle Aspirate (FNA) specimens under CEN WI 00140128, 00140126, and 00140129. Laboratories and stakeholders should consider both this and related standards for a comprehensive approach to molecular diagnostics using in situ detection techniques.

Keywords: ISO 20166-4, FFPE tissue, in situ detection, pre-examination processes, molecular in vitro diagnostics, immunohistochemistry, in situ hybridization, pathology laboratory, sample handling, tissue processing, biomolecule detection, laboratory standards